Temperature excursions are inevitable. The real risk is the time lost deciding what to do. See how preplanned governance can turn long quarantines into routine events.
- The Silent Stockout: No One Owns The Data That Would Have Caught It
- Token Costs Will Decide Clinical Supply AI
- What Is "Demand" When There Are No Sales?
- The Reliance Trap: When Regulatory Strategy Becomes A Clinical Supply Problem
- Clinical Trial Supply Chains Are Entering The Era Of Predictive Risk Management
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- CSM Feasibility Begins With Research Strategy And Study Design
- Clinical Supply Systems Need IT General Controls
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Ensuring On-Time Release Of CAR-T Cell Treatment In Spain
Due to the COVID-19 pandemic, and the start of Brexit, a CAR-T cell treatment therapy shipment was offloaded multiple times by the airline, requiring an alternative transport solution.
-
Optimizing IRT For Clinical Supply Management
Experts speak on supply capabilities within interactive response technology (IRT) – how flexibility is important to functionality and who to involve and which questions to ask in optimizing IRT for clinical supply.
-
Manual Assembly Strategies For Early‑Phase Combination Product Supply
Early‑phase combination products rely on manual assembly. Clear process design, quality controls, and collaboration help clinical supply teams reduce risk and maintain trial‑ready flexibility.
-
Modern Architecture's Impact On UX In Next-Gen Interactive Response Tech
Explore how Interactive Response Technologies (IRTs) built around microservices models can provide faster initial builds, more rapid change management, and improved built-in test automation.
-
Advancing Your API To First Human Dose Trials More Efficiently
Learn how end-to-end support for development and manufacturing, clinical trial services, advanced drug delivery, and commercial packaging can accelerate drug development and time to market.
-
Advantages Of Robotic Aseptic Processing
Examine the robotic technologies poised to increase manufacturing flexibility and efficiency while minimizing risk when bringing biologics to market.
-
How A Biotech Startup Transformed Its Clinical Trial Supply Management
Don’t let your trial get lost in the shuffle of legacy vendors. See how a high-touch, consultative approach can protect your study’s future.
-
Controlled Substances In Clinical Trials
Handling controlled substances presents layers of complexity. Partnering with an experienced CDMO is essential for managing scheduled materials during clinical studies.
-
Transportation Solutions For Cell And Gene Therapy Supply Chains
Developing a strong supply chain for your cell and gene therapy can make your company a more attractive target for acquisition as well as a more competitive player in the commercial environment.
-
How Intelligent IRT Is Redefining Clinical Supply Chains
Traditional clinical supply chains can't keep up. Learn how smart IRT platforms use real-time data to prevent shortages, cut waste, and keep trials running smoothly.
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
- Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.